WVEWave Life Sciences Ltd.

$3B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-34.8% YoY

Gross Profit

-$42M-1422.2% margin

Operating Income

-$54M-1849.7% margin

Net Income

-$51M-1731.9% margin

EPS (Diluted)

$-1.48

QoQ Revenue Growth

-61.6%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$347M

Total Liabilities

$232M

Stockholders' Equity

$115M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-34.8%
Gross Profit	-$42M	-$28M	-46.8%
Operating Income	-$54M	-$38M	-41.7%
Net Income	-$51M	-$38M	-34.8%

WVE Q3 2019 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena